Mikó, Edit
Sipos, Adrienn
Tóth, Emese
Lehoczki, Andrea
Fekete, Monika
Sebő, Éva
Kardos, Gábor
Bai, Péter http://orcid.org/0000-0002-6191-6616
Funding for this research was provided by:
NKFIH (K142141, FK128387, FK146852, TKP2021-EGA-20)
NFKIH (TKP2021-EGA-19)
Magyar Tudományos Akadémia (POST-COVID2021-33, NKM2022-30)
University of Debrecen
Article History
Received: 20 May 2024
Accepted: 12 June 2024
First Online: 26 June 2024
Declarations
:
: Péter Bai is a CEO and shareholder of Holobiont Diagnostics LTD, a developer of cancer diagnostic tests. Other authors declare no conflict of interest.